ASTH (ASTH) Misses Q3 EPS by 46c ; Offers Guidance

ASTH (NASDAQ: ASTH) reported Q3 EPS of $0.01, $0.46 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $956 million versus the consensus estimate of $952.86 million.

GUIDANCE:

ASTH sees FY2025 revenue of $3.1-3.18 billion, versus the consensus of $3.21 billion.

For earnings history and earnings-related data on ASTH (ASTH) click here.

You May Also Be Interested In

• Citi upgrades O-I Glass to Buy with $9 price target, opens 90-Day upside catalyst watch
• TD Cowen Starts Lakefront Biotherapeutics (LKFT) at Buy
• Ross Stores, Inc. (ROST) PT Raised to $290 at Citi